Table 2. Point mutation FA patients.
Patient | Sex | Mutation | GAA repeats | Age | Age at onset | Disease duration | Frataxin protein pg/µg total protein | Frataxin protein % | Frataxin mRNA % |
1 | M | p.I154F | 959 | 42 | 6 | 36 | 3.60 | 9.3 | 33 |
2 | M | p.I154F | 921 | 44 | 13 | 31 | 5.20 | 13.5 | 48 |
3 | M | c.482+3delA | 731 | 46 | 9 | 37 | 10.34 | 26.8 | 52 |
4 | F | p.R165P | 988 | 34 | 4 | 30 | 21.10 | 54.7 | 67 |
5 | F | p.R165P | 926 | 43 | 10 | 33 | 23.40 | 60.6 | 75 |
Demographics, neurological data, frataxin protein and FXN mRNA levels in pFA. Frataxin protein % and FXN mRNA levels % are expressed as relative to the control group.